ViOptix, Inc. gives clinicians a revolutionary new capability — to obtain non-invasive, objective, real-time measurement of oxygen saturation (StO2) in the soft tissues affected by breast reconstruction and other surgical procedures – to help improve patient surgical outcomes by detecting problems before symptoms are visible.
ViOptix novel technology platform is built into three proprietary products:
Together, these products help to improve surgical outcomes, reduce patient time in the ICU, provide clinicians with faster feedback in the event of a problem and save money for the payer.
Alex Keller, MD
